MOMOSTOCKS

[jedijazz]

$GTCH GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) announced today that GBT Tokenize Corp (“GBT/Tokenize”) engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm device. For more than 20 years, M2 has been providing a full range of regulatory, quality and clinical consulting services to US and international medical technology firms. M2 specializes in devices, biologics and combination products that are reviewed by FDA's Center for Devices and Radiological Health (CDRH).